For example, combination of MUC5AC or MUC16 with CA19-9 antigen improved diagnostic performance in discriminating pancreatic cancer from benign conditions over the CA19-9 assay alone15. This evidence concerns the gene MUC16 and familial pancreatic carcinoma.